Cargando…
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
BACKGROUND: Natriuretic peptides are involved in the cascade of pathophysiological events occurring in liver cirrhosis, counterbalancing vasoconstriction and anti-natriuretic factors. The effects of natriuretic peptides as treatment of cirrhotic ascites have been investigated only in small studies,...
Autores principales: | Gantzel, Rasmus Hvidbjerg, Kjær, Mikkel Breinholt, Jepsen, Peter, Aagaard, Niels Kristian, Watson, Hugh, Gluud, Lise Lotte, Grønbæk, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099106/ https://www.ncbi.nlm.nih.gov/pubmed/35646272 http://dx.doi.org/10.4254/wjh.v14.i4.827 |
Ejemplares similares
-
Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022) -
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021) -
Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies
por: Calanna, Salvatore, et al.
Publicado: (2013) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020) -
Helicobacter pylori infection and peptic ulcer disease in cirrhotic patients: An updated meta-analysis
por: Wei, Lin, et al.
Publicado: (2021)